Dr. Reddy’s Stakes Claim In U.S. OTC Market With Leiner Deal
This article was originally published in The Tan Sheet
Executive Summary
Dr. Reddy's Laboratories' foothold in the U.S. OTC drug market appears ready for expansion after the firm signed an exclusive 15-year OTC product development and marketing agreement with Leiner Health Products